✦ LIBER ✦

A systematic review of the effectiveness of docetaxel and mitoxantrone for the treatment of metastatic hormone-refractory prostate cancer

✍ Scribed by Collins, R; Trowman, R; Norman, G; Light, K; Birtle, A; Fenwick, E; Palmer, S; Riemsma, R

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

879 Docetaxel (DOC) and mitoxantrone (MI

✍ A. Heidenreich; C. Ohlmann; P. Olbert; A. Hegele 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase II of weekly docetaxel for hormo

✍ J.M. Ferrero; C. Foa; S. Thezenas; P. Ronchin; F. Peyrade; B. Valenza; X. Tehikn 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

613 Docetaxel (DOC) and mitoxantrone (MI

✍ A. Heidenreich; A. Schrader; P. Olbert; C. Ohlmann; A. Hegel; R. Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 225 KB

306 DOCETAXEL (DOC) AND MITOXANTRON (MIT

✍ C.H. Ohlmann; K. Breitenbach; D. Pfister; U. Engelmann; A. Heidenreich 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB

Successful treatment of metastatic hormo

✍ Brandon M Hayes-Lattin; Peter A Kovach; W.David Henner; Tomasz M Beer 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 88 KB

309 THE PREDICTIVE VALUE OF CHROMOGRANIN

✍ A. Gernone; S. Trabucco; V. Pagliarulo; G. Troccoli; A. Pagliarulo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB